Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts

[1]  S. Chatterjee,et al.  Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort. , 2002, The Journal of pharmacology and experimental therapeutics.

[2]  L. Verotta,et al.  Synthesis and biological evaluation of hyperforin analogues. Part I. Modification of the enolized cyclohexanedione moiety. , 2002, Journal of natural products.

[3]  T. Tsintsadze,et al.  Modulation of Ion Channels in Rat Neurons by the Constituents of Hypericum Perforatum , 2001, Pharmacopsychiatry.

[4]  S. Chatterjee,et al.  Stimulation of Glutamate, Aspartate and Gamma-Aminobutyric Acid Release from Synaptosomes by Hyperforin , 2001, Pharmacopsychiatry.

[5]  M. Gobbi1,et al.  In Vitro Binding Studies with Two Hypericum Perforatum Extracts - Hyperforin, Hypericin and Biapigenin - on 5-HT6, 5-HT7, GABAA/Benzodiazepine, Sigma, NPY-Y1 /Y2 Receptors and Dopamine Transporters , 2001 .

[6]  E. Ernst,et al.  St John's wort: Prozac from the plant kingdom. , 2001, Trends in pharmacological sciences.

[7]  S. Hansen,et al.  Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity. , 2001, Life sciences.

[8]  J. Greeson,et al.  St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature , 2001, Psychopharmacology.

[9]  J. Vry,et al.  Comparison of hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism , 1999, European Neuropsychopharmacology.

[10]  O. Krishtal,et al.  Hyperforin attenuates various ionic conductance mechanisms in the isolated hippocampal neurons of rat. , 1999, Life sciences.

[11]  W. Müller,et al.  Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1. , 1999, The Journal of pharmacology and experimental therapeutics.

[12]  M. Gobbi,et al.  Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[13]  C. Gambarana,et al.  Efficacy of an Hypericum Perforatum (St. John's Wort) Extract in Preventing and Reverting a Condition of Escape Deficit in Rats , 1999, Neuropsychopharmacology.

[14]  S. Kaehler,et al.  Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus , 1999, Neuroscience Letters.

[15]  V. Zlotnik,et al.  Neuropharmacology of St. John's Wort (Hypericum) , 1998, The Annals of pharmacotherapy.

[16]  S. Bhattacharya,et al.  Hyperforin as a possible antidepressant component of hypericum extracts. , 1998, Life sciences.

[17]  S S Chatterjee,et al.  Activity profiles of two hyperforin-containing hypericum extracts in behavioral models. , 1998, Pharmacopsychiatry.

[18]  S. Chatterjee,et al.  Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human Volunteers , 1998, Pharmacopsychiatry.

[19]  M Kieser,et al.  St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. , 1998, Pharmacopsychiatry.

[20]  U. Hafner,et al.  Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. , 1998, Pharmacopsychiatry.

[21]  S. Caccia.  Metabolism of the Newer Antidepressants , 1998, Clinical pharmacokinetics.

[22]  A. Nahrstedt,et al.  Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. , 1997, Pharmacopsychiatry.

[23]  H. Volz.  Controlled Clinical Trials of Hypericum Extracts in Depressed Patients - an Overview , 1997, Pharmacopsychiatry.

[24]  A. Privat,et al.  Sedative activity in mice of a hydroalcohol extract of Hypericum perforatum L. , 1997 .

[25]  C. Mulrow,et al.  St John's wort for depression—an overview and meta-analysis of randomised clinical trials , 1996, BMJ.

[26]  A. Meli,et al.  Is the forced swimming test a suitable model for revealing antidepressant activity? , 2004, Psychopharmacology.

[27]  W. Burkard,et al.  Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system. , 1999, Journal of receptor and signal transduction research.